PGR and breast cancer: Hormone receptor [estrogen receptor (ER), progesterone receptor (PR)] and human epidermal receptor 2 (HER2) categorize BC into molecular subtypes, and also serve as prominent prognostic biomarkers (Pashayan et al., 2020).